CN105007910B - 眼部感染的治疗或预防药物的制造用途 - Google Patents

眼部感染的治疗或预防药物的制造用途 Download PDF

Info

Publication number
CN105007910B
CN105007910B CN201380059141.4A CN201380059141A CN105007910B CN 105007910 B CN105007910 B CN 105007910B CN 201380059141 A CN201380059141 A CN 201380059141A CN 105007910 B CN105007910 B CN 105007910B
Authority
CN
China
Prior art keywords
dendrimer
integer
conjunctivitis
macromolecular
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201380059141.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN105007910A (zh
Inventor
贾辛丝·金凯德·费尔利
科林·保罗·巴雷特
杰里米·罗伯特·亚瑟·保罗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Starpharma Pty Ltd
Original Assignee
Starpharma Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Starpharma Pty Ltd filed Critical Starpharma Pty Ltd
Priority to CN201810557127.1A priority Critical patent/CN108452316B/zh
Publication of CN105007910A publication Critical patent/CN105007910A/zh
Application granted granted Critical
Publication of CN105007910B publication Critical patent/CN105007910B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201380059141.4A 2012-09-13 2013-09-13 眼部感染的治疗或预防药物的制造用途 Active CN105007910B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810557127.1A CN108452316B (zh) 2012-09-13 2013-09-13 眼部感染的治疗或预防方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261700714P 2012-09-13 2012-09-13
US61/700,714 2012-09-13
PCT/US2013/059810 WO2014043576A1 (en) 2012-09-13 2013-09-13 Method of treatment or prophylaxis of infections of the eye

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201810557127.1A Division CN108452316B (zh) 2012-09-13 2013-09-13 眼部感染的治疗或预防方法

Publications (2)

Publication Number Publication Date
CN105007910A CN105007910A (zh) 2015-10-28
CN105007910B true CN105007910B (zh) 2019-03-19

Family

ID=50278734

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201380059141.4A Active CN105007910B (zh) 2012-09-13 2013-09-13 眼部感染的治疗或预防药物的制造用途
CN201810557127.1A Active CN108452316B (zh) 2012-09-13 2013-09-13 眼部感染的治疗或预防方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201810557127.1A Active CN108452316B (zh) 2012-09-13 2013-09-13 眼部感染的治疗或预防方法

Country Status (9)

Country Link
US (2) US10149885B2 (https=)
EP (1) EP2895161B1 (https=)
JP (2) JP6419701B2 (https=)
CN (2) CN105007910B (https=)
CA (1) CA2884897C (https=)
DK (1) DK2895161T3 (https=)
ES (1) ES2633778T3 (https=)
IN (1) IN2015DN02233A (https=)
WO (1) WO2014043576A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009008006A2 (en) * 2007-07-06 2009-01-15 Lupin Limited Pharmaceutical compositions for gastrointestinal drug delivery
RU2667118C1 (ru) * 2017-11-15 2018-09-14 Федеральное государственное бюджетное научное учреждение "Прикаспийский зональный научно-исследовательский ветеринарный институт" Универсальное средство в виде мази для комплексного лечения глазных болезней животных и способ его получения
CN110664757B (zh) * 2018-11-19 2022-08-02 成都瑞沐生物医药科技有限公司 纳米晶滴眼剂、其制备方法及其应用
EP3930730A4 (en) * 2020-04-15 2022-05-11 Starpharma Pty Limited PROPHYLAXIS FOR CORONAVIRUS AND/OR RESPIRATORY SYNCYTIAL VIRUS INFECTION

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1154123A (zh) * 1994-06-15 1997-07-09 生物分子研究所 抗病毒树枝状体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1305374A (zh) 1998-07-14 2001-07-25 法玛西雅厄普约翰美国公司 治疗眼部感染的噁唑烷酮
AUPP584298A0 (en) 1998-09-14 1998-10-08 Starpharma Limited Antimicrobial and antiparasitic agents
AUPR412801A0 (en) * 2001-03-30 2001-05-03 Starpharma Limited Agent for the prevention and treatment of sexually transmitted disease s - I
WO2005007223A2 (en) * 2003-07-16 2005-01-27 Sasha John Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations
SI1755616T1 (sl) * 2004-04-08 2014-04-30 Eye Co Pty Ltd. Zdravljenje eksudativne retinopatije z mineralkortikoidi
EP1937284B1 (en) 2005-10-18 2015-12-02 Starpharma Pty Limited Microbicidal dendrimer composition delivery system
AU2006308511B2 (en) * 2005-10-25 2013-06-13 Starpharma Pty Limited Macromolecular compounds having controlled stoichiometry
NZ583333A (en) * 2006-05-31 2011-06-30 Medihoney Pty Ltd Medicinal Compositions Containing Honey
JP5484339B2 (ja) * 2007-10-05 2014-05-07 ウェイン ステート ユニバーシティー 合成物の持続的な放出のためのデンドリマー
WO2010096558A1 (en) * 2009-02-18 2010-08-26 Eyeon Particle Sciences Llc Bi-functional co-polymer use for ophthalmic and other topical and local applications
PL2451822T3 (pl) * 2009-07-07 2014-01-31 Adenovir Pharma Ab Nowe związki przeciwwirusowe użyteczne do leczenia epidemicznego zapalenia spojówek i rogówki (keratoconjonctivitis) lub do zapobiegania
RS59598B1 (sr) 2011-05-16 2020-01-31 Starpharma Pty Ltd Postupak lečenja ili profilakse bakterijske vaginoze

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1154123A (zh) * 1994-06-15 1997-07-09 生物分子研究所 抗病毒树枝状体

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Dendrimers as therapeutic agents: a systematic review, Virendra Gajbhiye et al.Journal of Pharmacy and Pharmacology,2009,Vol.61,pages989-1003.;Virendra Gajbhiye et al;《Journal of Pharmacy and Pharmacology》;20091231;第61卷;989-1003 *

Also Published As

Publication number Publication date
US11219691B2 (en) 2022-01-11
US20150238557A1 (en) 2015-08-27
WO2014043576A1 (en) 2014-03-20
EP2895161B1 (en) 2017-05-03
JP2019001827A (ja) 2019-01-10
DK2895161T3 (en) 2017-08-21
US10149885B2 (en) 2018-12-11
HK1212619A1 (en) 2016-06-17
IN2015DN02233A (https=) 2015-08-21
ES2633778T3 (es) 2017-09-25
JP6419701B2 (ja) 2018-11-07
US20190070249A1 (en) 2019-03-07
JP2015528509A (ja) 2015-09-28
EP2895161A1 (en) 2015-07-22
EP2895161A4 (en) 2016-03-23
CN108452316A (zh) 2018-08-28
CA2884897C (en) 2021-07-27
CA2884897A1 (en) 2014-03-20
JP6766114B2 (ja) 2020-10-07
CN108452316B (zh) 2022-04-15
CN105007910A (zh) 2015-10-28

Similar Documents

Publication Publication Date Title
CN102429862B (zh) 一种聚维酮碘眼用缓释滴眼液
RU2448736C1 (ru) Офтальмологическая композиция с амфотерным поверхностно-активным веществом и гиалуроновой кислотой
CN102342941A (zh) 表面两性聚合物和低聚物的眼耳科组合物
ES3003920T3 (en) Aqueous suspension preparation comprising nanoparticles of macrolide antibacterial agent
CN101129385B (zh) 含加替沙星和依碳酸氯替泼诺的眼用组合物及其制备方法
CN103269686A (zh) 隐形眼镜用眼科组合物
CN105007910B (zh) 眼部感染的治疗或预防药物的制造用途
US20220287961A1 (en) Compositions and methods for treatment of ocular diseases
CN107753424A (zh) 一种不含防腐剂的多剂量包装抗炎滴眼液及其制备方法
TWI773949B (zh) 碳量子點及其製備方法與用途
JP5812465B2 (ja) 抗アカントアメーバ用組成物、アカントアメーバ角膜炎の予防及び治療剤並びにコンタクトレンズケア溶液
CN101278905A (zh) 含那他霉素的眼用组合物、用途及其制作方法
CN101278908B (zh) 一种左氧氟沙星滴眼液
US20180221407A1 (en) Ophthalmic compositions for therapeutic and prophylactic uses
Maulvi et al. Mel4-coated hyaluronic acid-laden etafilcon A contact lenses: Improved wettability with retained antimicrobial properties
CN106265720A (zh) 一种复合人工泪液及其制备方法
CN105999239A (zh) 一种盐酸溶菌酶滴眼液及其制备方法和应用
HK1212619B (en) Method of treatment or prophylaxis of infections of the eye
RU2755298C1 (ru) Раствор для ухода за контактными линзами
CN100387220C (zh) 银黄眼用制剂及其制备方法
CN111643448A (zh) 一种盐酸莫西沙星眼用凝胶剂及其制备方法
CN117562858A (zh) 甲苯磺酸妥舒沙星滴眼液及其制备方法
CN104083323A (zh) 包含妥布霉素和倍他米松的眼用混悬液
JPWO2005072727A1 (ja) 点眼剤組成物
TW202114690A (zh) 以費洛西洛韋（ｆｉｌｏｃｉｃｌｏｖｉｒ）治療或預防眼部感染之組合物及方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant